JP2018505228A5 - - Google Patents

Download PDF

Info

Publication number
JP2018505228A5
JP2018505228A5 JP2017561611A JP2017561611A JP2018505228A5 JP 2018505228 A5 JP2018505228 A5 JP 2018505228A5 JP 2017561611 A JP2017561611 A JP 2017561611A JP 2017561611 A JP2017561611 A JP 2017561611A JP 2018505228 A5 JP2018505228 A5 JP 2018505228A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
optionally substituted
cycloalkyl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017561611A
Other languages
English (en)
Japanese (ja)
Other versions
JP6807337B2 (ja
JP2018505228A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/018233 external-priority patent/WO2016133995A1/en
Publication of JP2018505228A publication Critical patent/JP2018505228A/ja
Publication of JP2018505228A5 publication Critical patent/JP2018505228A5/ja
Application granted granted Critical
Publication of JP6807337B2 publication Critical patent/JP6807337B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017561611A 2015-02-17 2016-02-17 ミトコンドリア治療剤としてのフェノチアジン類似体 Expired - Fee Related JP6807337B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562117205P 2015-02-17 2015-02-17
US62/117,205 2015-02-17
PCT/US2016/018233 WO2016133995A1 (en) 2015-02-17 2016-02-17 Phenothiazine analogues as mitochondrial therapeutic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020169793A Division JP7113055B2 (ja) 2015-02-17 2020-10-07 ミトコンドリア治療剤としてのフェノチアジン類似体

Publications (3)

Publication Number Publication Date
JP2018505228A JP2018505228A (ja) 2018-02-22
JP2018505228A5 true JP2018505228A5 (https=) 2020-04-09
JP6807337B2 JP6807337B2 (ja) 2021-01-06

Family

ID=56692740

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017561611A Expired - Fee Related JP6807337B2 (ja) 2015-02-17 2016-02-17 ミトコンドリア治療剤としてのフェノチアジン類似体
JP2020169793A Expired - Fee Related JP7113055B2 (ja) 2015-02-17 2020-10-07 ミトコンドリア治療剤としてのフェノチアジン類似体
JP2022118006A Pending JP2022141896A (ja) 2015-02-17 2022-07-25 ミトコンドリア治療剤としてのフェノチアジン類似体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020169793A Expired - Fee Related JP7113055B2 (ja) 2015-02-17 2020-10-07 ミトコンドリア治療剤としてのフェノチアジン類似体
JP2022118006A Pending JP2022141896A (ja) 2015-02-17 2022-07-25 ミトコンドリア治療剤としてのフェノチアジン類似体

Country Status (7)

Country Link
US (3) US10472340B2 (https=)
EP (1) EP3258938B1 (https=)
JP (3) JP6807337B2 (https=)
AU (3) AU2016220096B2 (https=)
CA (1) CA2976776C (https=)
DK (1) DK3258938T3 (https=)
WO (1) WO2016133995A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10472340B2 (en) 2015-02-17 2019-11-12 Arizona Board Of Regents On Behalf Of Arizona State University Substituted phenothiazines as mitochondrial agents
AU2016220153B2 (en) 2015-02-17 2020-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
WO2017218537A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
US12570622B2 (en) 2016-08-25 2026-03-10 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US11390605B2 (en) 2016-08-25 2022-07-19 Arizona Board Of Regents On Behalf Of Arizona State University Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
US10745366B2 (en) 2016-08-25 2020-08-18 Arizon Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
WO2018129411A1 (en) * 2017-01-06 2018-07-12 Bioelectron Technology Corporation Aryl- and heteroaryl-resorufin derivatives for treatment of oxidative stress disorders and liver and kidney disorders
FR3063495B1 (fr) 2017-03-02 2019-04-05 Provepharm Life Solutions Procede de preparation de l’iodure de 3,7-bis(dimethylamino)phenothiazine-5-ylium
CN108484527B (zh) * 2018-04-27 2022-01-14 成都恒昊创新科技有限公司 一种10h-吩噻嗪类铁死亡抑制剂及其制备方法与应用
AU2019311859B2 (en) 2018-07-22 2025-12-18 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
FI4385512T3 (fi) * 2018-07-26 2026-01-12 Taurx Therapeutics Man Ltd Diaminofenotiatsiinien optimoitu annostus populaatioille
US12110313B2 (en) 2019-02-28 2024-10-08 Arizona Board Of Regents On Behalf Of Arizona State University Engineered bacterial ribosome compositions and methods
EP4291552B1 (en) * 2021-02-09 2025-04-09 Boehringer Ingelheim International GmbH Modulators of complex i
CN119504646A (zh) * 2024-11-07 2025-02-25 长春工业大学 新型含有吩噻嗪结构药物小分子的合成及抗肿瘤活性研究

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476722A (en) 1966-08-15 1969-11-04 Goodrich Co B F Process for polymerizing acrylic acid esters
DE2315349A1 (de) 1973-03-28 1974-10-03 Bayer Ag Nicht verfaerbende alterungsschutzmittel
JPS5168569A (en) 1974-12-10 1976-06-14 Fuji Photo Film Co Ltd 2 2 44 torimechiru 66 hidorokishi 77 chikankuromanruino seizoho
FR2471052B1 (fr) * 1979-11-28 1985-10-11 Kuraray Co Photo-electrode pour cellule photo-electrochimique et son procede de fabrication
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US5220042A (en) 1984-01-26 1993-06-15 Otsuka Pharmaceutical Co., Ltd. 1,4-benzoquinone derivatives and benzene derivatives, and process for preparing the same
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
US5356898A (en) 1991-01-31 1994-10-18 Warner-Lambert Company Substituted 4,6-di-tertiary-butyl 5-hydroxy-pyrimidines
WO1996031217A1 (en) 1995-04-04 1996-10-10 Duke University Inhibiting retroviral replication
JP2001209176A (ja) 1999-04-02 2001-08-03 Fuji Photo Film Co Ltd 光重合性組成物およびそれを用いた記録材料
WO2001062233A2 (en) 2000-02-25 2001-08-30 F. Hoffmann La Roche Ag Adenosine receptor modulators
AU2001280445A1 (en) 2000-06-23 2002-01-08 Vanderbilt University Novel chain-breaking antioxidants
MXPA04000613A (es) 2001-07-20 2004-05-05 Ligand Pharm Inc DERIVADOS DE aCIDO PIRIDINILO Y PIRIMIDILTRIENOICO COMO MODULADORES DE RECEPTOR DE RETINOIDE X.
CA2489439A1 (en) * 2002-06-17 2003-12-24 Verification Technologies, Inc. Materials for optical medium copy-protection transiently reacting to a reader beam
CA2505603A1 (en) 2002-11-18 2004-06-03 Genospectra, Inc. Caged sensors, regulators and compounds and uses thereof
US20060188866A1 (en) 2005-02-18 2006-08-24 Children's Hospital Oakland Research Institute Diaminophenothiazine compositions and uses thereof
EP1863796A1 (en) 2005-03-22 2007-12-12 NeuroSearch A/S Pyrazolyl-pyrimidines as potassium channel modulating agents and their medical use
MY148145A (en) 2006-07-11 2013-03-15 Wista Lab Ltd Methods of synthesis and/or purification of diaminophenothiazinium compounds
AU2008265045B2 (en) 2007-06-19 2014-02-27 Taurx Therapeutics Management Ltd. Phenothiazine compounds for treating Mild Cognitive Impairment
US8268849B2 (en) 2007-09-25 2012-09-18 Board Of Regents Of The University Of Nebraska Multifunctional Antioxidants and methods of use thereof
CA2906990A1 (en) 2008-04-04 2009-10-08 Duke University Non-invasive systems and methods for in-situ photobiomodulation
US8389583B2 (en) 2008-05-23 2013-03-05 Zurex Pharma, Inc. Antimicrobial compositions and methods of use
US8772301B2 (en) 2009-12-18 2014-07-08 Sunovion Pharmaceuticals, Inc. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
WO2011103536A1 (en) 2010-02-19 2011-08-25 Arizona Board Of Regents Multifunctional radical quenchers and their use
JP5868955B2 (ja) * 2010-04-30 2016-02-24 プロセッタ アンチバイラル インコーポレイテッド 抗ウイルス化合物
EP2606022A2 (en) 2010-08-16 2013-06-26 Santhera Pharmaceuticals (Schweiz) AG Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
DE102010043379A1 (de) 2010-11-04 2012-05-10 Bayer Schering Pharma Aktiengesellschaft Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung
EP2450893A1 (de) 2010-11-08 2012-05-09 Bayer MaterialScience AG Photopolymer-Formulierung zur Herstellung holographischer Medien mit hoch vernetzten Matrixpolymeren
WO2012125983A1 (en) * 2011-03-17 2012-09-20 Prosetta Antiviral Inc. Antiviral treatments
EP2694478B1 (en) 2011-04-04 2018-08-22 Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University Methylene violet analogs as multifunctional radical quenchers for the treatment of mitochondrial dysfunction
KR101270160B1 (ko) 2011-05-16 2013-05-31 아주대학교산학협력단 가변색 이광자 형광프로브, 이를 이용한 미토콘드리아 내 티올 활성의 영상화 방법 및 이의 제조방법
WO2013120040A1 (en) 2012-02-10 2013-08-15 Children's Medical Center Corporation Targeted pathway inhibition to improve muscle structure, function and activity in muscular dystrophy
WO2013120081A1 (en) 2012-02-10 2013-08-15 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University 1h- pyrrolo [2, 3 -b] pyridine derivatives and their use as radical quenchers
WO2014055629A1 (en) 2012-10-03 2014-04-10 Arizona Board Agents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona Multifunctional radical quenchers for the treatment of mitochondrial dysfunction
AU2013329171A1 (en) 2012-10-10 2015-04-30 Arizona Board Of Regents, On Behalf Of Arizona State University Multifunctional radical quenchers
US20140275045A1 (en) 2013-03-15 2014-09-18 Edison Pharmaceuticals, Inc. Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
US10472340B2 (en) 2015-02-17 2019-11-12 Arizona Board Of Regents On Behalf Of Arizona State University Substituted phenothiazines as mitochondrial agents
AU2016220153B2 (en) 2015-02-17 2020-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
WO2017218537A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting
US11390605B2 (en) 2016-08-25 2022-07-19 Arizona Board Of Regents On Behalf Of Arizona State University Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
US10745366B2 (en) 2016-08-25 2020-08-18 Arizon Board Of Regents On Behalf Of Arizona State University Therapeutic compounds

Similar Documents

Publication Publication Date Title
JP2018505228A5 (https=)
AR063721A1 (es) Derivados de anilinopiperazina y composicion farmaceutica
SG11201900869QA (en) Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
CY1124620T1 (el) Οξυστερολες και μεθοδοι χρησης αυτων
PE20140171A1 (es) Pirazoles fungicidas y sus mezclas
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
BR112019000247A2 (pt) derivados de 1,3-di-hidróxi-fenila úteis como imunomoduladores
MX2019004578A (es) Oxisteroles y metodos de uso de los mismos.
EP4424314A3 (en) Substituted polycyclic pyridone derivative and prodrug thereof
MX2022004450A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1.
BR112018012921A2 (pt) compostos pirazol ou seus sais, seus métodos de preparação, composições herbicidas e seu uso
WO2003024967A3 (en) Indolizines as kinase protein inhibitors
AR087193A1 (es) Compuestos fungicidas 2-[2-cloro-4(4-cloro-fenoxi)-fenil]-1-[1,2,4]triazol-1il-etanol alquilo sustituidos
HRP20170104T1 (hr) Derivati tipa azaindazola ili diazaindazola za liječenje boli
CY1123154T1 (el) Παραγοντας ενισχυσης της επιδρασης αποκαταστασης μετα απο νευρικη βλαβη που περιλαμβανει ενα παραγωγο αλκυλαιθερα ή ενα αλας αυτου
MY198568A (en) Polycyclic carbamoylpyridone derivative
MX2018011716A (es) Compuesto de piridazinona o su sal, y herbicida que lo contiene.
EA201992771A1 (ru) Ингибитор поверхностного антигена вируса гепатита b
CY1119289T1 (el) Παραγωγα 1,3-διυδρο-2η-βενζιμιδαζολ-2-ονης υποκατεστημενα με ετεροκυκλικους δακτυλιους ως αντι-ιικοι παραγοντες αναπνευστικου συγκυτιακου ιου
MX2020003383A (es) Compuesto de griseofulvina y uso farmacéutico de este.
MX2018005133A (es) Intermediarios para preparar herbicidas de piridazinona y proceso para prepararlos.
PH12017501687A1 (en) Inhibitors of hepatitis c virus polymerase
PY2131467A (es) Derivados de heterociclos condensados sustituidos con 2–(het)arilo como plaguicidas
CY1122477T1 (el) Παραγωγα πυριδο-οξαζινονης ως αναστολεις tnap
MX2020002449A (es) Nuevos compuestos heterociclicos fungicidas.